NAACCR Item #3932: LDH Pretreatment Lab Value
Padding Character' '
|Item #||Length||Source of Standard||Year Implemented||Version Implemented||Year Retired||Version Retired||Column #|
|3932||7||NAACCR||2018||18||1898 - 1904|
NAACCR XML: Tumor.ldhPretreatmentLabValue
LDH (Lactate Dehydrogenase) Pretreatment Lab Value, measured in serum, is a predictor of treatment response, progression-free survival and overall survival for patients with Stage IV melanoma of the skin.
LDH (Lactate Dehydrogenase) Pretreatment Lab Value is a Registry Data Collection Variable in AJCC. It was previously collected as Melanoma Skin, CS SSF# 5.
|XXXXX.1||100,000 U/L or greater|
|XXXXX.7||Test ordered, results not in chart|
|XXXXX.8||Not applicable: Information not collected for this case
(If this item is required by your standard setter, use of code XXXXX.8 will result in an edit error.)
|XXXXX.9||Not documented in medical record
LDH (Lactate Dehydrogenase) Pretreatment Lab Value not assessed or unknown if assessed
Each Site-Specific Data Item (SSDI) applies only to selected primary sites, histologies, and years of diagnosis. Depending on applicability and standard-setter requirements, SSDIs may be left blank.